Absence of PD-L1 Protein Expression in Classic Dermatofibrosarcoma Protuberans
Dermato · 01.04.2026 · 6 (2) · 11
DOI: 10.3390/dermato6020011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermato, online erschienen am 01.04.2026. Verfasst von Thilo Gambichler und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to assess the prevalence of PD-L1 protein expression in dermatofibrosarcoma protuberans (DFSP) to provide insights into the potential use of immune checkpoint inhibitors.
Methods
We retrospectively analyzed formalin-fixed, paraffin-embedded primary DFSP specimens (n = 17). Diagnoses were confirmed by two senior dermatopathologists according to guideline criteria, including diffuse CD34 positivity and storiform spindle cell morphology. All cases represented conventional DFSP without fibrosarcomatous transformation. PD-L1 immunohistochemistry was carried out using a rabbit monoclonal antibody (ab205921, clone 28-8; Abcam). Only membranous staining in viable tumor cells was scored as a tumor proportion score (TPS), where >1% was considered positive. Any cytoplasmic staining without convincing membranous accentuation was not scored. PD-L1 staining in tumor-infiltrating immune cells was recorded separately. Five pleomorphic dermal sarcomas served as positive controls.
Results
The median age was 62 years (IQR 55–74); 12 patients were men and 5 were women. The primary sites were trunk (59%), upper extremity (35%), and lower extremity (6%); immunosuppression was present in 18%. By FNCLCC, 82% of tumors were G1 and 18% were G2; no G3 tumors were identified. All DFSPs were PD-L1-negative in DFSP cells (TPS ≤ 1%) and in tumor-infiltrating lymphocytess. Among controls, 3/5 pleomorphic dermal sarcomas were PD-L1-positive with the expected membranous pattern and variable intensity.
Conclusions
PD-L1 expression was absent in this cohort of conventional, predominantly low-grade DFSP, suggesting that classic DFSP is generally not an ideal candidate for PD-1/PD-L1-directed checkpoint blockade. These conclusions should not be extrapolated to fibrosarcomatous DFSP or metastatic disease, where PD-L1 expression has been reported. Selective PD-L1 testing may still be warranted in clinically aggressive scenarios (e.g., fibrosarcomatous transformation, unresectable recurrence, or metastasis).
Zitieren
APA
Gambichler, T., Devrim, Y., Weyer-Fahlbusch, S. S., & Susok, L. (2026). Absence of PD-L1 Protein Expression in Classic Dermatofibrosarcoma Protuberans. Dermato, 6(2), 11. https://doi.org/10.3390/dermato6020011
Vancouver
Gambichler T, Devrim Y, Weyer-Fahlbusch SS, Susok L. Absence of PD-L1 Protein Expression in Classic Dermatofibrosarcoma Protuberans. Dermato. 2026;6(2):11. doi:10.3390/dermato6020011
BibTeX
@article{Gambichler2026,
author = {Gambichler, Thilo and Devrim, Yusa and Weyer-Fahlbusch, Sera S. and Susok, Laura},
title = {Absence of PD-L1 Protein Expression in Classic Dermatofibrosarcoma Protuberans},
journal = {Dermato},
year = {2026},
volume = {6},
number = {2},
pages = {11},
doi = {10.3390/dermato6020011}
}
EUVIMED